American Shared Hospital Services (AMS)

American Shared Hospital Services (AMS) Healthcare & Pipeline Overview

American Shared Hospital Services provides specialized medical equipment and services, including Gamma Knife radiosurgery and proton beam radiation therapy. Operating primarily in the United States with a small presence in South America, AMS caters to healthcare providers seeking advanced treatment solutions for neurological disorders and cancer, facing competition from larger medical equipment providers.

What Is the Investment Thesis for AMS?

American Shared Hospital Services presents a focused investment opportunity within the niche market of radiosurgery and radiation therapy equipment leasing. Key value drivers include the continued demand for Gamma Knife procedures and proton beam radiation therapy. The company's established base of 115 Gamma Knife units in the U.S. provides a stable revenue stream. Growth catalysts include expanding PBRT services and securing new equipment leases. However, investors may want to evaluate the company's negative profit margin of -7.6% and the competitive landscape. The company's small market capitalization of $9.80M and beta of 0.13 indicate lower volatility but also limited liquidity. Monitoring the company's ability to improve profitability and expand its service offerings is crucial.

Based on FMP financials and quantitative analysis

AMS Key Highlights

• Market Cap of $9.80M indicates a small-cap company with potential for growth but also higher risk.
• P/E ratio of -6.17 reflects current unprofitability, requiring careful monitoring of future earnings potential.
• Gross Margin of 25.0% suggests some pricing power but also highlights the need for improved cost management.
• Beta of 0.13 indicates lower volatility compared to the market, potentially appealing to risk-averse investors.
• No Dividend Yield reflects a focus on reinvesting earnings for growth rather than returning capital to shareholders.

Who Are AMS's Competitors?

AMS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are AMS's Key Strengths?

• Specialized expertise in Gamma Knife and PBRT.
• Established relationships with hospitals and cancer centers.
• Recurring revenue from leasing and service agreements.
• Small beta indicating lower volatility.

What Are AMS's Weaknesses?

• Small market capitalization limits access to capital.
• Negative profit margin indicates financial challenges.
• Limited geographic diversification.
• Dependence on a small number of key technologies.

What Could Drive AMS Stock Higher?

• Expansion of existing PBRT facilities in Florida and California, potentially increasing treatment capacity and revenue generation.
• Potential new partnerships with hospitals and cancer centers to install additional Gamma Knife units, expanding market reach.
• Introduction of upgraded Gamma Knife technology with enhanced features, attracting new customers and retaining existing ones.
• Efforts to secure favorable reimbursement policies for Gamma Knife and PBRT procedures, improving profitability.

What Are the Key Risks for AMS?

• Financial-distress signal — its Altman Z-Score of 0.63 sits in the distress zone (elevated bankruptcy risk).
• Negative return on equity (-6.4%) — the business is not currently generating profit on shareholder capital.
• Competition from larger medical equipment providers with greater resources and broader product portfolios.
• Regulatory changes and reimbursement pressures impacting the profitability of Gamma Knife and PBRT services.
• Technological obsolescence rendering existing equipment less competitive.
• Economic downturn impacting hospital budgets and capital spending on medical equipment.
• Negative profit margin indicating financial instability and potential need for additional financing.

What Are the Growth Opportunities for AMS?

• Expansion of Proton Beam Radiation Therapy (PBRT) Services: The market for PBRT is growing due to its precision in treating tumors while minimizing damage to surrounding tissue. AMS operates PBRT systems in Florida and California. Expanding these facilities or adding new locations could significantly increase revenue. The global proton therapy market is projected to reach $2.5 billion by 2027, offering a substantial growth opportunity for AMS if they can capture a larger share of the market through strategic partnerships and investments.
• Increased Gamma Knife Unit Installations: AMS has a strong base of Gamma Knife units installed across the United States. By targeting hospitals and cancer centers in underserved areas, AMS can expand its installed base and generate recurring revenue through leasing and service agreements. The demand for non-invasive neurosurgical procedures is rising, driven by an aging population and technological advancements. Securing new contracts and installations will be critical for sustained growth.
• Strategic Partnerships with Healthcare Providers: Collaborating with leading hospitals and cancer centers can enhance AMS's market reach and credibility. These partnerships can involve joint ventures, equipment leasing agreements, or service contracts. By aligning with reputable institutions, AMS can gain access to a broader patient base and strengthen its competitive position. Exploring partnerships with international healthcare providers could also open new markets and revenue streams.
• Technological Upgrades and Innovation: Investing in the latest radiosurgery and radiation therapy technologies can attract new customers and retain existing ones. Upgrading existing Gamma Knife units with advanced features and exploring new treatment modalities can differentiate AMS from its competitors. Staying at the forefront of technological innovation is essential for maintaining a competitive edge and capturing market share in the rapidly evolving medical equipment industry.
• Expansion into International Markets: While AMS currently has a presence in South America, expanding into other international markets can diversify its revenue streams and reduce its reliance on the U.S. market. Targeting countries with growing healthcare infrastructure and a demand for advanced medical technologies can provide significant growth opportunities. Conducting thorough market research and establishing strategic partnerships are crucial for successful international expansion.

What Opportunities Does AMS Have?

• Expansion of PBRT services.
• Increased Gamma Knife unit installations.
• Strategic partnerships with healthcare providers.
• Technological upgrades and innovation.

What Threats Does AMS Face?

• Competition from larger medical equipment providers.
• Regulatory changes and reimbursement pressures.
• Technological obsolescence.
• Economic downturn impacting hospital budgets.

What Are AMS's Competitive Advantages?

• Specialized Expertise: Deep knowledge and experience in Gamma Knife radiosurgery and proton beam radiation therapy.
• Established Customer Base: Long-term relationships with hospitals and cancer centers.
• Recurring Revenue: Stable revenue stream from equipment leasing and service agreements.
• Barriers to Entry: High capital costs and regulatory requirements for setting up and operating radiosurgery and radiation therapy facilities.

What Does AMS Do?

Founded in 1980 and headquartered in San Francisco, California, American Shared Hospital Services (AMS) focuses on providing advanced medical technology solutions to healthcare providers. The company's primary business involves leasing radiosurgery and radiation therapy equipment, notably the Gamma Knife, a non-invasive tool used to treat brain tumors and other neurological conditions. AMS also offers proton beam radiation therapy (PBRT) services at facilities in Orlando, Florida, and Long Beach, California. These services include planning, installation, reimbursement support, and marketing assistance to its customers. AMS has established a significant presence with Gamma Knife units, operating 115 units in the United States and two in South America as of December 31, 2021. The company’s evolution has been marked by a commitment to providing cutting-edge technology and comprehensive support services, enabling healthcare providers to offer advanced treatment options. While the company has a niche focus, it operates in a competitive landscape with larger medical equipment and service providers. AMS aims to differentiate itself through specialized expertise and customer-focused support.

What Products and Services Does AMS Offer?

• Leases radiosurgery equipment, specifically Gamma Knife units, to healthcare providers.
• Provides financing services for Leksell Gamma Knife units.
• Offers proton beam radiation therapy (PBRT) services.
• Provides planning, installation, and reimbursement support services.
• Offers marketing support services to its customers.
• Operates Gamma Knife units in the United States and South America.
• Maintains and services the leased equipment.

How Does AMS Make Money?

• Equipment Leasing: Generates revenue by leasing Gamma Knife and other radiosurgery equipment to hospitals and clinics.
• Service Agreements: Provides maintenance, repair, and support services for the leased equipment, generating recurring revenue.
• PBRT Services: Operates proton beam radiation therapy centers, charging fees for treatment services.
• Financing: Offers financing options for customers acquiring Leksell Gamma Knife units.

What Industry Does AMS Operate In?

American Shared Hospital Services operates within the medical care facilities industry, a segment experiencing growth driven by technological advancements and increasing demand for specialized treatments. The market for radiosurgery and radiation therapy equipment is competitive, with larger players offering a broader range of products and services. AMS differentiates itself by focusing on Gamma Knife and proton beam technologies. The industry is subject to regulatory oversight and reimbursement policies, which can impact profitability. AMS's success depends on its ability to maintain a competitive edge through technological innovation and strong customer relationships.

Who Are AMS's Key Customers?

• Hospitals: Leases equipment and provides services to hospitals with oncology and neurosurgery departments.
• Cancer Centers: Partners with cancer centers to offer advanced radiation therapy options.
• Clinics: Provides equipment and services to specialized clinics focused on radiosurgery and radiation therapy.

American Shared Hospital Services Financial Trajectory

American Shared Hospital Services (AMS) reported $7.1M in revenue for Q1 2026, a decline of 8.3% compared to the prior quarter. The company recorded a net loss of $612K, with diluted EPS of $-0.09. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, AMS averaged $-0.06 in diluted EPS.

Company Profile

American Shared Hospital Services operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in San Francisco, US. The company is led by CEO Gary Delanois. AMS has traded publicly since 1984.

How American Shared Hospital Services Is Valued

American Shared Hospital Services carries a market capitalization of $9.80M, placing it in the micro-cap category. Relative to its peer group, AMS's quantitative score of 37/100 is below the peer average of 60/100.

ROE -6%Key Financial Metrics

Return on equity for American Shared Hospital Services stands at -6.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -2.8%, showing how much profit it generates from its asset base. Its free cash flow yield is -9.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.77 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -15.7%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 5/9Financial Health

American Shared Hospital Services's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.63 places it in the distress zone, a signal of elevated financial risk.

FY2026 estForward Outlook

Wall Street analysts project American Shared Hospital Services revenue of about $29.9M for fiscal 2026, with EPS near $-0.05.

Net buyingInsider Activity

The most recent 9 insider filings for American Shared Hospital Services break down as 0 sales and 9 purchases. On net that is roughly 696K shares acquired (about $202K) — insiders putting money in tends to read as conviction.

AMS Financials

AMS Latest News

AMS Analyst Consensus

AMS MoonshotScore

American Shared Hospital Services Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources